{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:01:48Z","timestamp":1791918108244,"version":"4.3.4"},"reference-count":46,"publisher":"International Society of Global Health","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Glob Health"],"DOI":"10.7189\/jogh.12.04076","type":"journal-article","created":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T16:43:28Z","timestamp":1668271408000},"source":"Crossref","is-referenced-by-count":11,"title":["Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa"],"prefix":"10.7189","volume":"12","author":[{"given":"Jeanne Perp\u00e9tue","family":"Vincent","sequence":"first","affiliation":[{"name":"Unit\u00e9 d'\u00c9pid\u00e9miologie des Maladies \u00c9mergentes, Institut Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gibril","family":"Ndow","sequence":"additional","affiliation":[{"name":"Division of Digestive Diseases, Department of Metabolism, Digestion & Reproduction, Imperial College London, London, United Kingdom"},{"name":"Disease Control & Elimination, MRC Unit The Gambia at London School of Hygiene & Tropical Medicine, Fajara, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amie","family":"Ceesay","sequence":"additional","affiliation":[{"name":"Disease Control & Elimination, MRC Unit The Gambia at London School of Hygiene & Tropical Medicine, Fajara, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramou","family":"Njie","sequence":"additional","affiliation":[{"name":"Edward Francis Small Teaching Hospital, Banjul, The Gambia"},{"name":"School of Medicine & Allied Health Sciences, University of The Gambia, Serekunda, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakary","family":"Sanneh","sequence":"additional","affiliation":[{"name":"National Public Health Laboratories, Ministry of Health, Serekunda, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignatius","family":"Baldeh","sequence":"additional","affiliation":[{"name":"National Public Health Laboratories, Ministry of Health, Serekunda, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"D\u2019Alessandro","sequence":"additional","affiliation":[{"name":"Disease Control & Elimination, MRC Unit The Gambia at London School of Hygiene & Tropical Medicine, Fajara, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maimuna","family":"Mendy","sequence":"additional","affiliation":[{"name":"International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Thursz","sequence":"additional","affiliation":[{"name":"Division of Digestive Diseases, Department of Metabolism, Digestion & Reproduction, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Chemin","sequence":"additional","affiliation":[{"name":"INSERM U1052, CNRS UMR5286, Centre de Recherche en Canc\u00e9rologie, Universit\u00e9 Claude Bernard, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan"},{"name":"Department of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Lemoine","sequence":"additional","affiliation":[{"name":"Division of Digestive Diseases, Department of Metabolism, Digestion & Reproduction, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Shimakawa","sequence":"additional","affiliation":[{"name":"Unit\u00e9 d'\u00c9pid\u00e9miologie des Maladies \u00c9mergentes, Institut Pasteur, Paris, France"},{"name":"International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4223","published-online":{"date-parts":[[2022,11,12]]},"reference":[{"key":"key-10.7189\/jogh.12.04076-202211121742-R1","unstructured":"World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Geneva: WHO Press; 2021."},{"key":"key-10.7189\/jogh.12.04076-202211121742-R2","unstructured":"World Health Organization. Global hepatitis report. Geneve: WHO; 2017. 2017."},{"key":"key-10.7189\/jogh.12.04076-202211121742-R3","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/liv.14843","article-title":"Epidemiological projections of viral-induced hepatocellular carcinoma in the perspective of WHO global hepatitis elimination.","volume":"41","author":"Vo Quang","year":"2021","journal-title":"Liver Int"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R4","doi-asserted-by":"publisher","first-page":"e1060","DOI":"10.1016\/S2214-109X(18)30344-9","article-title":"Liver cirrhosis in sub-Saharan Africa: neglected, yet important.","volume":"6","author":"Vento","year":"2018","journal-title":"Lancet Glob Health"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S2468-1253(16)30161-3","article-title":"Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium.","volume":"2","author":"Yang","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R6","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jhep.2016.10.013","article-title":"Battlefield against hepatitis B infection and HCC in Africa.","volume":"66","author":"Lemoine","year":"2017","journal-title":"J Hepatol"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis.","volume":"63","author":"EASL-ALEH","year":"2015","journal-title":"J Hepatol"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.","volume":"69","author":"EASL","year":"2018","journal-title":"J Hepatol"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R9","unstructured":"World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: WHO; 2015. Available: https:\/\/www.who.int\/publications\/i\/item\/9789241549059. Accessed: 22 August 2022."},{"key":"key-10.7189\/jogh.12.04076-202211121742-R10","unstructured":"World Health Organization. Guidelines on hepatitis B and C testing. Geneva: WHO; 2017. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK442272\/. Accessed: 22 August 2022."},{"key":"key-10.7189\/jogh.12.04076-202211121742-R11","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1186\/s12879-017-2767-0","article-title":"Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries.","volume":"17","author":"Ishizaki","year":"2017","journal-title":"BMC Infect Dis"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R12","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1186\/s12889-017-4630-z","article-title":"Prevalence of chronic hepatitis B virus infection and infrastructure for its diagnosis in Madagascar: Implication for the WHO\u2019s elimination strategy.","volume":"17","author":"Andriamandimby","year":"2017","journal-title":"BMC Public Health"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R13","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/liv.13393","article-title":"Are non-invasive fibrosis markers for chronic hepatitis B reliable in sub-Saharan Africa?","volume":"37","author":"Desalegn","year":"2017","journal-title":"Liver Int"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R14","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1136\/gutjnl-2015-309260","article-title":"The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa.","volume":"65","author":"Lemoine","year":"2016","journal-title":"Gut"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/MEG.0000000000001381","article-title":"Diagnostic accuracy of \u03b3-glutamyl transpeptidase-to-platelet ratio for predicting hepatitis B-related fibrosis: a meta-analysis.","volume":"31","author":"Lian","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R16","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00535-017-1425-z","article-title":"Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis.","volume":"53","author":"Shirabe","year":"2018","journal-title":"J Gastroenterol"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R17","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/srep01065","article-title":"A serum sweet-doughnut protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis.","volume":"3","author":"Kuno","year":"2013","journal-title":"Sci Rep"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R18","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3390\/ijms21030949","article-title":"Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi.","volume":"21","author":"Baudi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3343\/alm.2021.41.1.16","article-title":"Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver Diseases.","volume":"41","author":"Tamaki","year":"2021","journal-title":"Ann Lab Med"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R20","doi-asserted-by":"publisher","first-page":"220","DOI":"10.4254\/wjh.v12.i5.210","article-title":"Usefulness of Mac-2 binding protein glycosylation isomer in non-invasive probing liver disease in the Vietnamese population.","volume":"12","author":"Pham","year":"2020","journal-title":"World J Hepatol"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R21","doi-asserted-by":"publisher","first-page":"e22261","DOI":"10.1002\/jcla.22261","article-title":"M2BPGi as a potential diagnostic tool of cirrhosis in Chinese patients with Hepatitis B virus infection.","volume":"32","author":"Wei","year":"2018","journal-title":"J Clin Lab Anal"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R22","doi-asserted-by":"publisher","first-page":"e0220663","DOI":"10.1371\/journal.pone.0220663","article-title":"Wisteria floribunda agglutinin-positive Mac-2binding protein in the prediction of disease severity in chronic hepatitis B patients.","volume":"14","author":"Yeh","year":"2019","journal-title":"PLoS One"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R23","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/liv.13341","article-title":"Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development.","volume":"37","author":"Kim","year":"2017","journal-title":"Liver Int"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3350\/cmh.2018.0073","article-title":"Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection.","volume":"26","author":"Kim","year":"2020","journal-title":"Clin Mol Hepatol"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R25","doi-asserted-by":"publisher","first-page":"e559","DOI":"10.1016\/S2214-109X(16)30130-9","article-title":"Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study.","volume":"4","author":"Lemoine","year":"2016","journal-title":"Lancet Glob Health"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R26","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1136\/gutjnl-2015-309892","article-title":"Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia.","volume":"65","author":"Shimakawa","year":"2016","journal-title":"Gut"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R27","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab327","article-title":"Prevalence and clinical significance of occult hepatitis B infection in The Gambia, West.","author":"Ndow","year":"2021","journal-title":"J Infect Dis"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R28","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1111\/liv.12814","article-title":"Birth order and risk of hepatocellular carcinoma in chronic carriers of hepatitis B virus: A case-control study in The Gambia.","volume":"35","author":"Shimakawa","year":"2015","journal-title":"Liver Int"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R29","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/jvh.12561","article-title":"Implementation of an in-house quantitative real-time polymerase chain reaction method for Hepatitis B virus quantification in West African countries.","volume":"23","author":"Ghosh","year":"2016","journal-title":"J Viral Hepat"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R30","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1093\/cid\/ciz412","article-title":"Hepatitis B Core-related Antigen: An Alternative to Hepatitis B Virus DNA to Assess Treatment Eligibility in Africa.","volume":"70","author":"Shimakawa","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R31","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/apt.12561","article-title":"Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: the PROLIFICA experience in The Gambia.","volume":"39","author":"Lemoine","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R32","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1148\/radiol.2015151516","article-title":"STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies.","volume":"277","author":"Bossuyt","year":"2015","journal-title":"Radiology"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R33","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/hep.20027","article-title":"The Gambia Liver Cancer Study: Infection with Hepatitis B and C and the Risk of Hepatocellular Carcinoma in West Africa.","volume":"39","author":"Kirk","year":"2004","journal-title":"Hepatology"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3350\/cmh.2020.0032","article-title":"Novel biomarkers for the management of chronic hepatitis B.","volume":"26","author":"Inoue","year":"2020","journal-title":"Clin Mol Hepatol"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R35","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3892\/etm.2020.8922","article-title":"Comparison of the diagnostic performance of magnetic resonance elastography and Wisteria foribunda agglutinin-positive Mac-2-binding protein in the determination of advanced liver fibrosis stages in patients with chronic liver disease.","volume":"20","author":"Wu","year":"2020","journal-title":"Exp Ther Med"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R36","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3892\/etm.2020.8798","article-title":"Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B.","volume":"20","author":"Tsuji","year":"2020","journal-title":"Exp Ther Med"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R37","doi-asserted-by":"publisher","first-page":"7169","DOI":"10.12659\/MSM.916533","article-title":"Diagnostic Accuracy of Acoustic Radiation Force Impulse (ARFI) and Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein (WFA+-M2BP) in Patients with Chronic Liver Disease.","volume":"25","author":"Chen","year":"2019","journal-title":"Med Sci Monit"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R38","doi-asserted-by":"publisher","DOI":"10.1038\/s41424-018-0020-9","article-title":"Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection.","volume":"9","author":"Mak","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R39","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/hepr.12703","article-title":"Clinical implications of serum Wisteria floribunda agglutinin-positive Mac-2-binding protein in treatment-na\u00efve chronic hepatitis B.","volume":"47","author":"Ishii","year":"2017","journal-title":"Hepatol Res"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R40","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3343\/alm.2018.38.4.348","article-title":"Diagnosis of Liver Fibrosis With Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA-M2BP) Among Chronic Hepatitis B Patients.","volume":"38","author":"Jekarl","year":"2018","journal-title":"Ann Lab Med"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R41","doi-asserted-by":"publisher","first-page":"6705","DOI":"10.3748\/wjg.v23.i36.6705","article-title":"Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B.","volume":"23","author":"Noguchi","year":"2017","journal-title":"World J Gastroenterol"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R42","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/hepr.12712","article-title":"Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection.","volume":"47","author":"Ichikawa","year":"2017","journal-title":"Hepatol Res"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/liv.13188","article-title":"Serum WFA(+) -M2BP levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection.","volume":"37","author":"Zou","year":"2017","journal-title":"Liver Int"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R44","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/jvh.12575","article-title":"Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein for patients with chronic hepatitis B and C: a comparative study.","volume":"23","author":"Nishikawa","year":"2016","journal-title":"J Viral Hepat"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R45","doi-asserted-by":"publisher","first-page":"e3328","DOI":"10.1097\/MD.0000000000003328","article-title":"Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus.","volume":"95","author":"Heo","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"key-10.7189\/jogh.12.04076-202211121742-R46","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/hep4.1321","article-title":"Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection.","volume":"3","author":"Jun","year":"2019","journal-title":"Hepatol Commun"}],"container-title":["Journal of Global Health"],"original-title":[],"link":[{"URL":"https:\/\/jogh.org\/2022\/jogh-12-04076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T16:43:32Z","timestamp":1668271412000},"score":1,"resource":{"primary":{"URL":"https:\/\/jogh.org\/2022\/jogh-12-04076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,12]]},"references-count":46,"URL":"https:\/\/doi.org\/10.7189\/jogh.12.04076","relation":{},"ISSN":["2047-2978","2047-2986"],"issn-type":[{"value":"2047-2978","type":"print"},{"value":"2047-2986","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,12]]},"article-number":"04076"}}